Clinical Trials Logo

Clinical Trial Summary

This is a double-blind placebo-controlled study to evaluate the effect of Naltrexone (NTX) and counseling on highly active antiretroviral treatment (HAART) medication adherence in a cohort of HIV-infected patients who report heavy drinking, or meet criteria for alcohol abuse and/or dependence, and inadequate (< 95%) HAART adherence. All patients will receive a behavioral intervention, termed Medical Management/Medication Coaching or MM/MC. MM/MC incorporates the behavioral platform Medical Management (MM) from the National Institute on Alcohol Abuse and Alcoholism (NIAAA)-funded COMBINE Study to reduce heavy alcohol use with Medication Coaching (MC), a manualized treatment designed to improve HAART medication adherence in HIV-infected patients with substance use disorders.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Reduction in Heavy Drinking in Patients With HIV

NCT number NCT01227044
Study type Interventional
Source Yale University
Contact
Status Completed
Phase Phase 2/Phase 3
Start date April 2011
Completion date August 2017